Pediatric BMT Program
THURSDAY – FEBRUARY 12
A parallel track of sessions on hematopoietic stem cell transplants for children and adolescents will be held throughout the day on Thursday, February 12, at the 2009 BMT Tandem Meetings in Tampa. The programs are coordinated by the ASBMT Pediatric BMT Special Interest Group and the Pediatric Blood and Marrow Transplant Consortium (PBMTC).
10:30 am
Preventing Relapse after Transplantation for Pediatric ALL – Peri-transplant, Targeted and Cellular Therapies
■ Pre- and Post-Transplant Chemotherapy, Antibody and Targeted Therapies
Michael Pulsipher, MD
■ Minimal Residual Disease and Chimerism
Peter Bader, MD, PhD
■ Peri-Transplant Cellular Therapeutics
Laurence J.N. Cooper, MD, PhD
12:30 pm
Pediatric International Session Symposium and Luncheon
Sandeep Soni, MD, Carmem Bonfim, MD, and Richard P. Kadota, MD, Co-Chairs
■ Haplo-Identical Stem Cell Transplant Experience in China
Xiaojun Huang, MD, PhD
■ Innovative Supportive Care Practices in India
Mammen Chandy, MD
■ Cord Blood Biology, Transplantation and Tissue Regeneration Applications in Israel
Arnon Nagler, MD, MSc
1:45 pm
Transplant and Immunotherapies for Pediatric Solid Tumors
■ Update on Autologous Stem Cell Transplantation for Neuroblastoma
Stephan A. Grupp, MD, PhD
■ Can Antibody Therapy Replace Autologous Stem Cell Transplantation for
Neuroblastoma
Brian H. Kushner, MD
■ Cell and Vaccine-Based Therapies for High-Risk Pediatric Cancers
Alan S. Wayne, MD
1:45 pm
Transplant vs. Non-Transplant for Treatment of Challenging Hematological Disorders
■ Paroxysmal Nocturnal Hemoglobinuria (PNH)
Charles J. Parker, MD
■ Hypoplastic Myelodysplastic Syndrome/Aplastic Anemia
Robert A. Brodsky, MD
■ Kostmann’s Syndrome
John Levine, MD
3:20 pm
Controversies of and Unique Issues in BMT Infant Leukemia
Kirk R. Schultz, MD, Chair
■ Juvenile Myelomonocytic Leukemia: From Bench to Beside and Back Again
Mignon L. Loh, MD
■ Infant Leukemia: Is Transplantation the Answer?
Steve P. Hunger, MD
■ Special Considerations and Complications Related to the Long-Term Outcome after
Infant BMT
Scott Baker, MD
3:20 pm
Wiskott Aldrich Syndrome
Neena Kapoor, MD, and Morton J. Cowan, MD, Co-Chairs
■ Biology, Phenotype, Genotype of WAS
Hans D. Ochs, MD
■ Update of Treatment Outcome of WAS – the US Experience
Alexandra H. Filipovich, MD
■ Transplant Outcome of Reduced-Intensity Conditioning for WAS
Paul Veys, MD
5:05 pm
Pediatric Best Abstracts
6:15 pm
Pediatric Posters (Included in Poster Session I)
7:30 pm
Meeting of the Pediatric Blood and Marrow Transplant Consortium (PBMTC)